These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19124369)

  • 1. Stem cell therapy: the great promise in lung disease.
    Siniscalco D; Sullo N; Maione S; Rossi F; D'Agostino B
    Ther Adv Respir Dis; 2008 Jun; 2(3):173-7. PubMed ID: 19124369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fibrosis: Is stem cell therapy the way forward?
    Ikrama M; Usama M; Israr S; Humayon M
    J Taibah Univ Med Sci; 2024 Feb; 19(1):82-89. PubMed ID: 37876594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?
    Kokturk N; Yıldırım F; Gülhan PY; Oh YM
    Am J Stem Cells; 2018; 7(3):56-71. PubMed ID: 30245915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
    Willis GR; Fernandez-Gonzalez A; Reis M; Mitsialis SA; Kourembanas S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Release of Encapsuled Stromal-Derived Factor 1α Improves Bone Marrow Mesenchymal Stromal Cells Migration.
    Bajdak-Rusinek K; Fus-Kujawa A; Jelonek K; Musiał-Kulik M; Buszman PP; Żyła-Uklejewicz D; Sekowska AW; Kasperczyk J; Buszman PE
    Bioengineering (Basel); 2022 Dec; 9(12):. PubMed ID: 36550960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review.
    Chen X; Wang F; Huang Z; Wu Y; Geng J; Wang Y
    Int J Med Sci; 2021; 18(13):2849-2870. PubMed ID: 34220313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portable Automated Oxygen Administration System for hypoxaemic patients.
    Alzoubi K; Alguraan Z; Ramahi OM
    Springerplus; 2016; 5():470. PubMed ID: 27217985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Regulation of Gene Expression of Alveolar Epithelial Cell Markers in Human Lung Adenocarcinoma-Derived A549 Clones.
    Kondo H; Miyoshi K; Sakiyama S; Tangoku A; Noma T
    Stem Cells Int; 2015; 2015():165867. PubMed ID: 26167183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-based therapy in lung regenerative medicine.
    Yang J; Jia Z
    Regen Med Res; 2014 Dec; 2(1):7. PubMed ID: 25984335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice.
    Skurikhin EG; Pershina OV; Reztsova AM; Ermakova NN; Khmelevskaya ES; Krupin VA; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Dygai AM
    PLoS One; 2015; 10(4):e0125065. PubMed ID: 25927611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethics and policy issues for stem cell research and pulmonary medicine.
    Lowenthal J; Sugarman J
    Chest; 2015 Mar; 147(3):824-834. PubMed ID: 25732448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of regenerative medicine in the man-agement of traumatic patients.
    Moradi M; Hood B; Moradi M; Atala A
    J Inj Violence Res; 2015 Jan; 7(1):27-35. PubMed ID: 25618439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical use of regenerative therapy in COPD.
    Lipsi R; Rogliani P; Calzetta L; Segreti A; Cazzola M
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1389-96. PubMed ID: 25548520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.
    Basma H; Gunji Y; Iwasawa S; Nelson A; Farid M; Ikari J; Liu X; Wang X; Michalski J; Smith L; Iqbal J; El Behery R; West W; Yelamanchili S; Rennard D; Holz O; Mueller KC; Magnussen H; Rabe K; Castaldi PJ; Rennard SI
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L552-65. PubMed ID: 24487392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on the use of stem cells for autism treatment.
    Siniscalco D; Bradstreet JJ; Sych N; Antonucci N
    Stem Cells Int; 2013; 2013():262438. PubMed ID: 24222772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regeneration of alveolar type I and II cells from Scgb1a1-expressing cells following severe pulmonary damage induced by bleomycin and influenza.
    Zheng D; Limmon GV; Yin L; Leung NH; Yu H; Chow VT; Chen J
    PLoS One; 2012; 7(10):e48451. PubMed ID: 23119022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension.
    Hansmann G; Fernandez-Gonzalez A; Aslam M; Vitali SH; Martin T; Mitsialis SA; Kourembanas S
    Pulm Circ; 2012; 2(2):170-81. PubMed ID: 22837858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?
    Siniscalco D; Sapone A; Cirillo A; Giordano C; Maione S; Antonucci N
    J Biomed Biotechnol; 2012; 2012():480289. PubMed ID: 22496609
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.